Snoretox to Present at Leading Global Veterinary Conference in 2026

Snoretox has been selected to present its recently published research at one of the world’s most prestigious veterinary conferences: the ACVIM Forum in Seattle, June 2026.

This internationally recognised meeting brings together leading veterinary specialists and represents the highest standards of clinical and scientific excellence. Acceptance is highly competitive and reflects the quality and growing relevance of Snoretox’s work.

Presenting at the forum marks an important milestone for the company and highlights its increasing recognition within the global veterinary community.

‘The Veterinary Journal’ publishes our ground breaking research.

Clinical observations of tetanus toxin plus decoy, Snoretox-1, a novel targeted stimulant, in a pilot study of 6 British Bulldogs with BOAS’
Anthony Sasse, Luke J. Norbury, Thomas McLean, Maurice Newport, Arthur House, David W. Swift, Danny Aliano, Peter M. Smooker, Russell Conduit.

Click here to read the full article.

Click here to download the full article.

Click here to see the dog video results.

Help us help BOAS dogs

We’ll send you news and ways to be involved in giving BOAS dogs a better life.